Micardis 01
Micardis Hct Tablet
Product Images NDC 0597-0042
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Micardis Hct (NDC 0597-0042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Micardis 02
Micardis 03
Micardis 04
Micardis 05
Micardis 06
Micardis 07
This text is a product label for Micardis HCT tablets. It contains information regarding the dosage, ingredients and manufacturer of the tablets. It also provides guidance on storage and administration. Finally, there is a QR code which can be scanned for further product information or there is a phone number for Boehringer Ingelheim Pharmaceuticals, Inc. for prescribing information.*
Micardis 08
Micardise HCT is a medication in tablet form that contains both telmisartan and hydrochlorothiazide. It comes in a container that has three blister cards with ten tablets each, for a total of 30 tablets. It is important to note that the tablets are moisture-sensitive and should not be removed from the blister until immediately before taking. Dosage information should be read carefully, and the medication should be kept out of reach of children. For more information or to obtain prescribing information, call Boehringer Ingelheim Pharmaceuticals, Inc. at 1-800-562-6257.*
Micardis 09
Micardis HCT is a medicine containing telmisartan and hydrochlorothiazide used to treat high blood pressure. The package contains 30 tablets, 3 blister cards of 10 tablets each, with a strength of 80mg/25mg. The tablets are moisture-sensitive and not to be removed from the blisters until immediately before administration. The manufacturer is Boehringer Ingelheim Pharmaceuticals, Inc. The package has a National Drug Code of 0597-0042-37. Refer to accompanying prescribing information for dosage instructions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
